Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Neuroinflammatory priming: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam | 0.789 | neurodegeneration | What are the mechanisms by which gut mic |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.907
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Resveratrol protection against renal I/R injury in diabetic rats | validation | diabetic nephropathy | 0.900 | 0.00 | streptozotocin-induced diabeti | proposed | N/A |
| TLR expression analysis in Parkinson's disease patients | clinical | Parkinson's disease | 0.850 | 0.00 | human patients | proposed | N/A |
| Resveratrol effects on HK-2 cells under hypoxia/reoxygenation | exploratory | diabetic nephropathy | 0.850 | 0.00 | HK-2 cells cultured in high gl | proposed | N/A |
| TLR4 Activation Assay with NETs and Anti-CarP Antibodies | exploratory | rheumatoid arthritis | 0.850 | 0.00 | HEK293 TLR4 reporter cells | proposed | N/A |
| TLR expression in α-synuclein overexpressing mice | validation | Parkinson's disease | 0.800 | 0.00 | mice overexpressing human α-sy | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] | Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia | J Inflamm Res | 2022 | 1 |
| Podocyte TLR4 deletion alleviates diabetic kidney disease through prohibiting PK [PMID:40659086] | Li Z, Tan D, Lin J, Zhang T, Liu B et al | J Adv Res | 2026 | 0 |
| Celastrol treatment attenuates the inflammatory response in Alzheimer's disease [PMID:40762111] | Cao F, Zhang P, Zheng Z, Wang P, Wang Y | Neurol Res | 2026 | 0 |
| CircCramp1l targets the miR-532-3p/HMGB1/Drp1 axis to regulate allergic rhinitis [PMID:41519399] | Zhang Y, Wang J, Song Y, Chai J, Li L et | Biochem Pharmacol | 2026 | 0 |
| Neuronal TLR4 upregulation activates the cGAS-STING pathway to induce ferroptosi [PMID:41702081] | Qin H, Yang L, Du J, Xu X, Chen Z et al. | Int Immunopharmacol | 2026 | 0 |
| 2'-Fucosyllactose Alleviates Metabolic Hypertension in Mice via Gut Microbiota M [PMID:41926238] | Chen J, Liang S, Liu D, Yang S, Yan Q et | J Agric Food Chem | 2026 | 0 |
| Leveraging intraperitoneal delivery of toll-like receptor agonists to treat peri [PMID:41926324] | Yan H, Chia D, Ernst S, Demuytere J, Cos | Expert Opin Drug Deliv | 2026 | 0 |
| Small-molecule PCSK9 inhibition enhances BBB amyloid-β clearance and suppresses [PMID:41927877] | Miao J, Wang J, Zhou W, Guo J | Sci Rep | 2026 | 0 |
| Anti-carbamylated protein antibodies stabilize carbamylated Histone H3 to promot [PMID:41930627] | Nakabo S, Hanata N, Patino-Martinez E, H | Arthritis Rheumatol | 2026 | 0 |
| In silico design of a novel multi-epitope mRNA vaccine candidate for BtHKU5-CoV- [PMID:41931545] | Zheng N, Xu Y | PLoS Negl Trop Dis | 2026 | 0 |
| Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF. [PMID:41931597] | Ma B, Lyu W, Rizk J, Han X, Kjær M et al | Sci Immunol | 2026 | 0 |
| Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's di [PMID:41747877] | Waghmare A, Rahangdale S, Khare K, Taksa | Molecular and cellular neurosc | 2026 | 0 |
| Nanopiezoelectric 3D-Bioprinted Neural Organoid Models Epileptic Neuron-Microgli [PMID:41877549] | Chu J, Hu K, Lee WF, Xu SJ, Sun Z, Xu Y, | Nano letters | 2026 | 0 |
| The Neuroameliorative Effects of Enzymatically Modified Isoquercitrin and Sodium [PMID:41880086] | Hassouna I, Hassanein OH, El-Elaimy IA, | Neurochemical research | 2026 | 0 |
| Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An [PMID:41870813] | Upadhayay S | Molecular neurobiology | 2026 | 0 |
| Hyperglycaemia-induced metabolic stress and epigenetic imprinting in the inflamm [PMID:41730508] | Razi FB, Ashraf H, Singhal S, Qamar Z, M | Diabetes research and clinical | 2026 | 0 |
| Colonic Barrier Dysfunction and Inflammation Induced by Nano-/Micro-Plastics Fib [PMID:41923296] | Li Y, Bao S, Huang P, Wang J, Li H, Liu | Journal of applied toxicology | 2026 | 0 |
| Artemisinin attenuates 3-nitropropionic acid-induced neurodegeneration via HMGB1 [PMID:41865324] | Mustafa AM, Mudhafar M, Elgindy AM, Esma | Archives of pharmacal research | 2026 | 0 |
| Curcumin and Glycyrrhiza glabra Synergistically Attenuate Alzheimer's Pathology [PMID:41920384] | Liu S, Yan J, Dong J | Neurochemical research | 2026 | 0 |
| The spleen-brain axis in Alzheimer's disease and related dementias: Integrating [PMID:41778859] | Yan J, Zhang J, Ye X, Wang H, Li H, Li W | Alzheimer's & dementia : the j | 2026 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning Neuroinflammatory priming in their description or question text
No additional research found